Industrial-strength financing; $500 million share buyback program; genetic screening collaboration.
HFF, in Florham Park, announced Thursday it has arranged $6 million in financing for two industrial buildings totaling 100,000 square feet in Secaucus. HFF worked on behalf of Bhasin Properties to secure the long-term, fixed-rate loan through Principal Real Estate Investors.
D&B reported Thursday results for the third quarter and announced that its board of directors has authorized a new $500 million share repurchase program. The new authorization is in addition to the remaining $25 million under the previous $200 million authorization, which the company, based in the Short Hills section of Millburn, plans to complete by the end of 2011.
On Thursday, GenPath Women’s Health, an Elmwood Park laboratory, in collaboration with GeneDX and BioReference Laboratories Inc., announced a genetic screening test that will identify more than 550 mutations in more than 160 diseases. Offered primarily through GenPath Women’s Health, which has contracts with most national insurance plans, the test will be offered by the patient’s physician, obstetrician or genetic counselor during the first trimester or prior to conception. The test will be available from GenPath in January 2012.